|
PinPoint Data Solutions
to showcase AI-enabled blood
test on the UK pavilion at
WHX Dubai 2026
(DUBAI)
-
A
pioneering AI-enabled
multi-cancer blood test,
developed with the NHS in
England, will be among the
headline innovations
featured on the
UK Pavilion
at WHX Dubai 2026, as UK
HealthTech takes the
spotlight on one of the
world’s most influential
healthcare stages.
PinPoint Data Science will
exhibit on the ABHI UK
Pavilion, joining a strong
delegation of UK life
sciences and health
technology companies
showcasing cutting-edge
advances across diagnostics,
medical technology, AI, and
digital health.
Designed to support earlier
diagnosis and help ease
pressure on healthcare
systems, the PinPoint Test
uses machine learning and
routinely collected blood
biomarkers to generate
clinically meaningful cancer
risk assessments. Validated
through a five-year
real-world evaluation, the
test is intended to act as a
diagnostic aid—helping
clinicians prioritize
patients more effectively
while reducing unnecessary
downstream testing.
Dr Nigel Sansom, Executive
Chair at PinPoint Data
Science, said: “We are
delighted to be attending
WHX Dubai this year. It is a
rare opportunity for an
innovator like PinPoint to
meet face-to-face with
decision makers and people
on the frontlines of
healthcare delivery in a
whole range of international
markets. We are here to
promote something new -
machine learning as an
upgrade to blood testing, a
cost-effective tool for
managing cancer risk more
effectively without
exploding budgets; a product
that grows and adapts with
you as the needs of your
healthcare service change.
These are the challenges of
the 21st century, and we’re
keen to work with partners
in any region to deliver
custom solutions.”
Now hosted at the Dubai
Exhibition Centre, Expo City
Dubai, WHX Dubai has evolved
into a global health
innovation summit, welcoming
over 4,000 visitors from 180
countries and providing a
major platform for
international collaboration
across healthcare.
The ABHI UK Pavilion will
highlight the breadth of UK
life sciences expertise from
medical devices and
diagnostics to digital
health, AI-driven solutions,
genomics, and pharma
services, helping companies
build partnerships that
deliver real-world impact.
As the exclusive UK
representative for Informa
Markets’ healthcare
portfolio, ABHI is proud to
lead one of the largest
national pavilions at the
show, supported by Invest
Northern Ireland, the Welsh
Government, and the
Department for Business and
Trade (DBT).
Michelle
Michelucci, Head of
International Events at
ABHI, said: “We are so
excited to be returning to
Dubai for WHX 2026 with a
strong delegation of UK
innovators. The event has
grown significantly in both
size and influence, and it’s
fantastic to see it
reimagined at its new home
in Expo City. From
early-stage start-ups to
global life sciences
leaders, the UK Pavilion
will once again highlight
the best of UK expertise on
one of the world’s most
influential stages. We
cannot wait to welcome our
companies to Dubai.”
The ABHI UK Pavilion remains
a key destination for
visitors, offering a central
location, strong national
branding, and tailored
exhibitor support including
in-market guidance, curated
networking opportunities,
and introductions to senior
healthcare buyers and
decision makers.
To
learn more about the ABHI UK
Pavilion at WHX Dubai 2026,
visit:
https://ukhealthcarepavilion.com/events/whx-dubai/
PRINT
THIS ARTICLE
|
